{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:15:20Z","timestamp":1783548920667,"version":"3.55.0"},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"69","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,12,26]]},"DOI":"10.18632\/oncotarget.23043","type":"journal-article","created":{"date-parts":[[2017,12,9]],"date-time":"2017-12-09T04:07:27Z","timestamp":1512792447000},"page":"113928-113937","source":"Crossref","is-referenced-by-count":31,"title":["Gestational diabetes mellitus is associated with decreased adipose and placenta peroxisome proliferator-activator receptor \u03b3 expression in a Chinese population"],"prefix":"10.18632","volume":"8","author":[{"given":"Yu","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Second Clinical Medical College of Jinan University, Shenzhen People\u2019s Hospital, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilian","family":"She","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Second Clinical Medical College of Jinan University, Shenzhen People\u2019s Hospital, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiong","family":"Sha","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Second Clinical Medical College of Jinan University, Shenzhen People\u2019s Hospital, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40618-016-0607-5","article-title":"Gestational diabetes mellitus: an updated overview","volume":"40","author":"Brunetti","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrendo.2016.127","article-title":"Long-term metabolic risk among children born premature or small for gestational age","volume":"13","author":"Hokken-Koelega","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"3","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.2337\/dc07-s202","article-title":"Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes","volume":"30","author":"Friedman","year":"2007","journal-title":"Diabetes care"},{"key":"4","first-page":"213","article-title":"Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue","volume":"44","author":"Lappas","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2337\/diacare.27.3.799","article-title":"Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes","volume":"27","author":"Zinman","year":"2004","journal-title":"Diabetes Care"},{"key":"6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.0001-6349.2004.00413.x","article-title":"Adiponectin is reduced in gestational diabetes mellitus in normal weight women","volume":"83","author":"Drevon","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13098-017-0205-5","article-title":"Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han population","volume":"9","author":"Shan","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10528-016-9765-6","article-title":"Association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2) gene with type 2 diabetes mellitus in ethnic kashmiri population","volume":"55","author":"Ganai","year":"2017","journal-title":"Biochem Genet"},{"key":"9","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1016\/j.dsx.2017.03.004","article-title":"Association of polymorphisms of peroxisome proliferator activated receptors in early and late onset of type 2 diabetes mellitus","volume":"11","author":"Ramteke","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10","doi-asserted-by":"crossref","first-page":"15712","DOI":"10.1073\/pnas.2536828100","article-title":"Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle","volume":"100","author":"Evans","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1111\/ejn.12281","article-title":"Peroxisome proliferator-activated receptor gamma-coactivator-1 alpha coordinates sphingolipid metabolism, lipid raft composition and myelin protein synthesis","volume":"38","author":"Franklin","year":"2013","journal-title":"Eur J Neurosci"},{"key":"12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1172\/JCI10843","article-title":"Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists","volume":"106","author":"Olefsky","year":"2000","journal-title":"J Clin Invest"},{"key":"13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"O\u2019Rahilly","year":"1999","journal-title":"Nature"},{"key":"14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Seed","year":"1998","journal-title":"Nature"},{"key":"15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mce.2013.06.027","article-title":"PPAR activation as a regulator of lipid metabolism, nitric oxide production and lipid peroxidation in the placenta from type 2 diabetic patients","volume":"377","author":"Jawerbaum","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"16","doi-asserted-by":"crossref","first-page":"E522","DOI":"10.1152\/ajpendo.00124.2001","article-title":"Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy","volume":"282","author":"Friedman","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"17","first-page":"779","article-title":"Gestational diabetes mellitus is associated with increased leukocyte peroxisome proliferator-activated receptor gamma expression","volume":"11","author":"Cypryk","year":"2015","journal-title":"Arch Med Sci"},{"key":"18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11892-011-0243-6","article-title":"Care of the infant of the diabetic mother","volume":"12","author":"Hay","year":"2012","journal-title":"Curr Diab Rep"},{"key":"19","first-page":"2070926","article-title":"Gestational diabetes mellitus and future cardiovascular risk: an Update","volume":"2016","author":"Lapolla","year":"2016","journal-title":"Int J Endocrinol"},{"key":"20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diabres.2012.03.011","article-title":"A prospective evaluation of neonatal hypoglycaemia in infants of women with gestational diabetes mellitus","volume":"97","author":"Pedro-Botet","year":"2012","journal-title":"Diab Res Clin Pract"},{"key":"21","doi-asserted-by":"crossref","first-page":"F65","DOI":"10.1136\/archdischild-2015-309750","article-title":"Diabetes in pregnancy and infant adiposity: systematic review and meta-analysis","volume":"102","author":"Modi","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR gamma is required for placental, cardiac, and adipose tissue development","volume":"4","author":"Evans","year":"1999","journal-title":"Mol Cell"},{"key":"23","first-page":"5017","article-title":"PPARgamma\/RXRalpha heterodimers control human trophoblast invasion","volume":"86","author":"Fournier","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"24","article-title":"Advances on PPARgamma research in the emerging era of precision medicine","author":"Zhao","year":"2017","journal-title":"Curr Drug Targets"},{"key":"25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1248\/bpb.b17-00030","article-title":"Activation of PPARgamma at an early stage of differentiation enhances adipocyte differentiation of MEFs derived from type II diabetic TSOD mice and alters lipid droplet morphology","volume":"40","author":"Atsumi","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1071\/RD04067","article-title":"15-Deoxy-Delta12,14-prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism","volume":"17","author":"Gonzalez","year":"2005","journal-title":"Reprod Fertil Dev"},{"key":"27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/molehr\/gah090","article-title":"Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women","volume":"10","author":"Gonzalez","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.placenta.2006.04.002","article-title":"Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy","volume":"28","author":"Hiramatsu","year":"2007","journal-title":"Placenta"},{"key":"29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1172\/JCI119562","article-title":"Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance","volume":"100","author":"Polonsky","year":"1997","journal-title":"J Clin Invest"},{"key":"30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/hmbci-2015-0025","article-title":"Maternal and fetal lipid metabolism under normal and gestational diabetic conditions","volume":"26","author":"Desoye","year":"2016","journal-title":"Horm Mol Biol Clin Investigation"},{"key":"31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/jcp.49.8.634","article-title":"Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study","volume":"49","author":"Lowy","year":"1996","journal-title":"J Clin Pathol"},{"key":"32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.17219\/acem\/38141","article-title":"Adiponectin levels in gestational diabetes mellitus and in pregnant women without glucose intolerance","volume":"24","author":"Onvural","year":"2015","journal-title":"Adv Clin Exp Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"C1600","DOI":"10.1152\/ajpcell.1993.264.6.C1600","article-title":"Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells","volume":"264","author":"Hofmann","year":"1993","journal-title":"Am J Physiol"},{"key":"34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","article-title":"PPAR gamma is required for the differentiation of adipose tissueand","volume":"4","author":"Mortensen","year":"1999","journal-title":"Mol Cell"},{"key":"35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR gamma and human metabolic disease","volume":"116","author":"O\u2019Rahilly","year":"2006","journal-title":"J Clin Invest"},{"key":"36","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm780","article-title":"A futile metabolic cycle activated in adipocytes by antidiabetic agents","volume":"8","author":"Lazar","year":"2002","journal-title":"Nature Med"},{"key":"37","doi-asserted-by":"crossref","first-page":"e44919","DOI":"10.1371\/journal.pone.0044919","article-title":"\u201cSeed-Milarity\u201d confers to hsa-miR-210 and hsa-miR-147b similar functional activity","volume":"7","author":"Rezzonico","year":"2012","journal-title":"PLoS One"},{"key":"38","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Quon","year":"2000","journal-title":"J Clin Endocrinol Metabol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T15:39:00Z","timestamp":1719675540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":38,"journal-issue":{"issue":"69","published-print":{"date-parts":[[2017,12,26]]}},"alternative-id":["23043","29371958"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23043","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}